🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07822711
Starting soon Not applicable

Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA

NCT07822711 · tracked via the Priya Life Science China tracker
Sponsor
Peking University Third Hospital
Phase
Not applicable
Started
2026-09-21
Last updated
2026-09-16

Condition(s) studied

Spinal Muscular Atrophy (SMA)

Investigational drug(s) / intervention(s)

Portable Isokinetic Knee Training Robot With an Individually Optimized Compliant SettingPortable Isokinetic Knee Training Robot With a Rigid Setting

Portable Isokinetic Knee Training Robot With an Individually Optimized Compliant Setting: The compliant setting will be individualized within the device's predefined safe stiffness range. At each candidate stiffness, the participant will perform five knee-extension repetitions. The stiffness producing the highest mean peak knee-extension torque while the movement remains painless, without obvious fatigue, and with a stable trajectory will be selected. The assigned limb will then train at this setting for up to 8 weeks, no more than five sessions per week. Each session will use a target angular velocity of 45 degrees per second, an individualized maximum voluntary pain-free range of motion, at least six sets of 10 extension-flexion repetitions per leg, and approximately 1 minute of rest between sets. Training volume will be matched to the contralateral limb.

Portable Isokinetic Knee Training Robot With a Rigid Setting: The assigned limb will train with the device's predefined rigid stiffness setting for up to 8 weeks, no more than five sessions per week. Each session will use a target angular velocity of 45 degrees per second, an individualized maximum voluntary pain-free range of motion, at least six sets of 10 extension-flexion repetitions per leg, and approximately 1 minute of rest between sets. Training volume will be matched to the contralateral limb.

Study summary

This randomized, within-participant, contralateral-limb-controlled clinical trial will compare individually optimized compliant and rigid stiffness settings of a portable isokinetic knee training robot in children with spinal muscular atrophy. At least 13 children aged 6 to 12 years will be enrolled. For each participant, one leg will be randomly assigned to the compliant setting and the contralateral leg to the rigid setting using sequentially numbered, opaque, sealed envelopes. Both legs will receive the same training volume, number of repetitions, and angular velocity for up to 8 weeks. The primary outcome is the between-setting difference in the change from baseline in peak isokinetic knee-extension torque. Secondary outcomes include knee-extension range of motion, quadriceps cross-sectional area on magnetic resonance imaging, femoral nerve conduction measures, and sit-to-stand performance. Knee pain, suprapatellar skin temperature, fatigue, and other adverse events will be monitored throughout the study.

Eligibility

Sex
ALL
Min age
6 Years
Max age
12 Years
Healthy volunteers
No
Inclusion Criteria: 1. Age 6 to 12 years. 2. Diagnosis of spinal muscular atrophy. 3. Able to maintain an independent seated position. 4. If receiving disease-modifying treatment, including nusinersen or risdiplam, the participant must have received a stable dose for at least 6 months before enrollment and must not change the treatment regimen during the study. Exclusion Criteria: 1. Any other major disease or medical condition that, in the investigator's judgment, would interfere with safe participation or interpretation of the study results. 2. The legal guardian declines to provide written informed consent, or the participant is unable to complete the study procedures. 3. Unable to undergo magnetic resonance imaging or electromyography and nerve conduction testing. 4. Blood pressure above the 95th percentile for age, sex, and height, as assessed by a clinician. 5. Lacks the cognitive capacity to understand or comply with the requirements of study participation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Peking University Third Hospital Beijing China

More Peking University Third Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07822711 on ClinicalTrials.gov ↗ ← All trials in China